Medical Foods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Medical Foods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

The global medical foods market reached a value of US$ 20.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 29.2 Billion by 2027, exhibiting a CAGR of 5.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Medical foods refer to food products that are formulated to be administered or consumed under the supervision of a physician or intended for the dietary management of diseases and conditions. They are composed of vitamins, minerals (like zinc and calcium), botanicals, coenzyme Q10 (CoQ10), taurine, omega-2 fatty acids and antioxidants. Due to the presence of these nutrients, medical foods manage nutritional deficiencies that affect disease progression and are healthier alternatives to naturally occurring foodstuffs used in a natural state. Medical foods also enhance the immune and digestive systems while aiding the cognitive behavior of consumers. Nowadays, they are available in various forms such as pills, pre-thickened products and puddings, powder and liquids for oral intake or enteral feeding by tube.

The global medical foods market is primarily driven by the rising prevalence of chronic diseases and the growing geriatric population. Medical food is specifically formulated and processed for the patients and is recommended by physicians to manage the symptoms of neurological conditions, multiple sclerosis, stroke, and dementia as patients face difficulty in swallowing food. Besides this, with the growing awareness regarding the need for clinical nutrition by healthcare professionals and patients, there has been an increased demand for medical food products. Furthermore, the rising penetration of the e-commerce industry has led to a gradual shift toward the online purchase of medical foods, thereby offering lucrative opportunities to market players. The rising adoption of healthy alternatives due to the increasing cost of medical services, increasing awareness about medical foods and extensive investment in research and development (R&D) activities are some of the other factors positively impacting the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical foods market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, route of administration, application and distribution channel.

Breakup by Product:

Pills
Powder
Others

Breakup by Route of Administration:

Oral
Enteral

Breakup by Application:

ADHD
Depression
Diabetes
Cancer
Alzheimer's Disease
Metabolic Disorders
Others

Breakup by Distribution Channel:

Supermarkets
Hospital and Retail Pharmacies
Online Pharmacies
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alfasigma S.p.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company LLC (Reckitt Benckiser), Medtrition Inc., Meiji Holdings Co. Ltd., Metagenics Inc. (Alticor), Nestlé S.A., Primus Pharmaceuticals Inc., Targeted Medical Pharma Inc. and Victus Inc.

Key Questions Answered in This Report:
How has the global medical foods market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global medical foods market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the application?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global medical foods market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Medical Foods Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Pills
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Powder
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Enteral
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 ADHD
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Depression
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Diabetes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Alzheimer's Disease
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Metabolic Disorders
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Supermarkets
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital and Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Alfasigma S.p.A.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Danone S.A.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Fresenius Kabi AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Mead Johnson & Company LLC (Reckitt Benckiser)
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 Medtrition Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Meiji Holdings Co. Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Metagenics Inc. (Alticor)
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 SWOT Analysis
15.3.9 Nestlé S.A.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Primus Pharmaceuticals Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Targeted Medical Pharma Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Victus Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings